Clinical studies indicated that FKBP5 dysregulation was prevalent in individuals with PTSD, and some gene variants increased susceptibility to PTSD after trauma exposure.69 Preclinical studies have also identified FKBP5 as a viable future target for the treatment of comorbid PTSD and AUD. The gene discussed is FKBP5; the disease is post-traumatic stress disorder.